Evolent Health, Inc.

Informe acción NYSE:EVH

Capitalización de mercado: US$2.8b

Evolent Health Dirección

Dirección controles de criterios 2/4

El CEO de Evolent Health's es Seth Blackley , nombrado en Jan 2011, tiene una permanencia de 13.25 años. compensación anual total es $7.73M, compuesta por 8.8% salario y 91.2% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.58% de las acciones de la empresa, por valor de $18.67M. La antigüedad media del equipo directivo y de la junta directiva es de 3.1 años y 3.8 años, respectivamente.

Información clave

Seth Blackley

Chief Executive Officer (CEO)

US$8.9m

Compensación total

Porcentaje del salario del CEO8.8%
Permanencia del CEO13.3yrs
Participación del CEO0.5%
Permanencia media de la dirección3.2yrs
Promedio de permanencia en la Junta Directiva3.9yrs

Actualizaciones recientes de la dirección

Recent updates

These 4 Measures Indicate That Evolent Health (NYSE:EVH) Is Using Debt Reasonably Well

May 05
These 4 Measures Indicate That Evolent Health (NYSE:EVH) Is Using Debt Reasonably Well

Evolent Health, Inc. (NYSE:EVH) Doing What It Can To Lift Shares

Apr 08
Evolent Health, Inc. (NYSE:EVH) Doing What It Can To Lift Shares

Evolent Health (NYSE:EVH) Is Experiencing Growth In Returns On Capital

Mar 12
Evolent Health (NYSE:EVH) Is Experiencing Growth In Returns On Capital

Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt

Jan 17
Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt

Many Still Looking Away From Evolent Health, Inc. (NYSE:EVH)

Dec 21
Many Still Looking Away From Evolent Health, Inc. (NYSE:EVH)

Evolent Health (NYSE:EVH) Is Looking To Continue Growing Its Returns On Capital

Nov 30
Evolent Health (NYSE:EVH) Is Looking To Continue Growing Its Returns On Capital

A First Evaluation On Evolent Health

Oct 04

Does Evolent Health (NYSE:EVH) Have A Healthy Balance Sheet?

Sep 29
Does Evolent Health (NYSE:EVH) Have A Healthy Balance Sheet?

There's Been No Shortage Of Growth Recently For Evolent Health's (NYSE:EVH) Returns On Capital

Sep 01
There's Been No Shortage Of Growth Recently For Evolent Health's (NYSE:EVH) Returns On Capital

An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 47% Undervalued

Aug 04
An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 47% Undervalued

Evolent Health: Business Economics Still Appealing, Reiterate Buy

Jul 19

Cautious Investors Not Rewarding Evolent Health, Inc.'s (NYSE:EVH) Performance Completely

Jun 14
Cautious Investors Not Rewarding Evolent Health, Inc.'s (NYSE:EVH) Performance Completely

Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt

May 30
Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt

An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 34% Undervalued

May 02
An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 34% Undervalued

Evolent Health (NYSE:EVH) Shareholders Will Want The ROCE Trajectory To Continue

Apr 17
Evolent Health (NYSE:EVH) Shareholders Will Want The ROCE Trajectory To Continue

Evolent Health GAAP EPS of $0.11 beats by $0.13, revenue of $382.4M beats by $9.47M

Feb 22

Is Evolent Health (NYSE:EVH) A Risky Investment?

Feb 19
Is Evolent Health (NYSE:EVH) A Risky Investment?

Evolent Health: Strengthening Fundamentals, Investing At High Rates Of Return

Feb 15

Is Evolent Health, Inc. (NYSE:EVH) Potentially Undervalued?

Feb 01
Is Evolent Health, Inc. (NYSE:EVH) Potentially Undervalued?

Evolent Health (NYSE:EVH) Might Have The Makings Of A Multi-Bagger

Jan 14
Evolent Health (NYSE:EVH) Might Have The Makings Of A Multi-Bagger

Evolent spikes as Humana partnership expands

Jan 12

Is Evolent Health, Inc. (NYSE:EVH) Trading At A 49% Discount?

Dec 27
Is Evolent Health, Inc. (NYSE:EVH) Trading At A 49% Discount?

Evolent Health offered $23.5M class action securities settlement

Sep 19

Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher

Sep 18
Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher

Evolent Health: Improving Financials, But There's More

Aug 31

Is Evolent Health (NYSE:EVH) A Risky Investment?

Aug 05
Is Evolent Health (NYSE:EVH) A Risky Investment?

Evolent Health initiated at outperform at RBC on organic revenue growth opportunity

Jul 29

Evolent Health: Strong Growth, Priced At 2x Sales, What To Know

Jul 11

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Seth Blackley en comparación con los beneficios de Evolent Health?
FechaCompensación totalSalarioIngresos de la empresa
Mar 31 2024n/an/a

-US$141m

Dec 31 2023US$9mUS$783k

-US$142m

Sep 30 2023n/an/a

-US$112m

Jun 30 2023n/an/a

-US$77m

Mar 31 2023n/an/a

-US$40m

Dec 31 2022US$8mUS$683k

-US$19m

Sep 30 2022n/an/a

-US$4m

Jun 30 2022n/an/a

-US$19m

Mar 31 2022n/an/a

-US$24m

Dec 31 2021US$7mUS$600k

-US$30m

Sep 30 2021n/an/a

-US$45m

Jun 30 2021n/an/a

-US$68m

Mar 31 2021n/an/a

-US$261m

Dec 31 2020US$4mUS$438k

-US$328m

Sep 30 2020n/an/a

-US$515m

Jun 30 2020n/an/a

-US$504m

Mar 31 2020n/an/a

-US$334m

Dec 31 2019US$3mUS$400k

-US$304m

Sep 30 2019n/an/a

-US$121m

Jun 30 2019n/an/a

-US$107m

Mar 31 2019n/an/a

-US$86m

Dec 31 2018US$2mUS$400k

-US$53m

Sep 30 2018n/an/a

-US$49m

Jun 30 2018n/an/a

-US$49m

Mar 31 2018n/an/a

-US$56m

Dec 31 2017US$2mUS$400k

-US$61m

Compensación vs. Mercado: La compensación total de Seth($USD8.93M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD6.66M).

Compensación vs. Ingresos: La compensación de Seth ha aumentado mientras la empresa no es rentable.


CEO

Seth Blackley (44 yo)

13.3yrs

Permanencia

US$8,931,188

Compensación

Mr. Seth Barrie Blackley serves as Chief Executive Officer at Evolent Health, Inc. since October 1, 2020. He serves as President of True Health Indiana, Inc. (True Health Indiana). Mr. Blackley co-founded...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Seth Blackley
Co-Founder13.3yrsUS$8.93m0.53%
$ 15.0m
Dan McCarthy
CEO of New Century Health & President1.7yrsUS$5.76m0.21%
$ 5.9m
John Johnson
Chief Financial Officer4.8yrsUS$3.53m0.13%
$ 3.7m
Emily Rafferty
Chief Operating Officerless than a yearUS$2.69m0.035%
$ 974.7k
Jonathan Weinberg
Chief Legal Officer10.3yrsUS$2.01m0.10%
$ 2.9m
Aammaad Shams
Chief Accounting Officer3.9yrsUS$634.88k0.017%
$ 481.9k
Robert Cruz
Chief Technology Officerno datasin datossin datos
Jessica White
Chief Information Officerless than a yearsin datossin datos
Seth Frank
Vice President of Investor Relations2.4yrssin datossin datos
Kali Beyah
Chief People & Brand Officer2.3yrssin datossin datos
John Tam
Chief Strategy Officer12.3yrssin datossin datos
Scott Pritchard
President of Performance Suiteno datasin datossin datos

3.2yrs

Permanencia media

39.5yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de EVH se considera experimentado (3.1 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Seth Blackley
Co-Founder6.1yrsUS$8.93m0.53%
$ 15.0m
Peter Grua
Independent Director4.3yrsUS$260.25k0.032%
$ 902.1k
Richard Jelinek
Independent Directorless than a yearUS$245.50k0.0015%
$ 41.5k
Russell Glass
Independent Directorless than a yearsin datos0.0053%
$ 147.8k
Cheryl Scott
Independent Chairperson of the Board & Lead Independent Director8.5yrsUS$347.75k0.034%
$ 947.8k
Diane Holder
Independent Director12.8yrsUS$265.25k0.048%
$ 1.3m
Mary Duffy
Independent Director6.7yrsUS$255.25k0.015%
$ 414.3k
Kim Keck
Independent Director3.3yrsUS$265.25k0.014%
$ 396.9k
Craig Barbarosh
Independent Director3.4yrsUS$257.50k0.015%
$ 420.7k
Toyin Ajayi
Independent Directorless than a yearUS$195.83k0%
$ 0

3.9yrs

Permanencia media

58yo

Promedio de edad

Junta con experiencia: La junta directiva de EVH se considera experimentada (3.8 años de antigüedad promedio).